InMed Pharmaceuticals INM
NASDAQ INM
$1.36 +0.02 (+1.48%)
As of: Oct 21, 2026 · 3:32 PM EDT

InMed Pharmaceuticals (INM) Debt Ratio (2021 - 2022)

Updated

InMed Pharmaceuticals' Debt Ratio came in at 0.00 for fiscal Q3 2022 (quarter ended Mar 31, 2022), down 37.4% from the prior quarter.

Analysis

InMed Pharmaceuticals (INM) Debt Ratio (2021 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Linde 231.45 Bn 213.03 Bn 4.43 Bn 0.32
2 Corning 116.59 Bn 109.15 Bn 1.63 Bn 0.26
3 Sherwin Williams 82.19 Bn 81.23 Bn 3.34 Bn 0.45
4 Air Products & Chemicals 67.40 Bn 62.58 Bn 1.04 Bn 0.43
5 LyondellBasell Industries 40.93 Bn 30.44 Bn 2.04 Bn 0.37
6 Nutrien 33.12 Bn 29.95 Bn 3.25 Bn 0.21
7 Qnity Electronics 25.20 Bn 22.33 Bn 666.00 Mn 0.28
8 Ppg Industries 24.54 Bn 17.20 Bn 1.81 Bn 0.31
9 Ati 24.54 Bn 22.56 Bn 309.80 Mn 0.38
10 InMed Pharmaceuticals 5.66 Mn 3.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 0.00
Dec 31, 2021 0.00
API Access

InMed Pharmaceuticals Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=INM&period=max&api_key=YOUR_API_KEY